Integrated proteomic, DNA methylation, and targeted Next Generation Sequencing reveals relevant heterogeneity in lower-grade meningioma and a new target in NF2 mutated meningiomas
PXD058651, PXD058653Shah et al., 2025
Overview
- Modality
- Proteomics (bulk MS)
- Sample count
- 30
- Patient count
- Not reported
- Institution
- University of Plymouth
- Corresponding author
- Vikram Sharma / C. Oliver Hanemann
- Platform
- Orbitrap Fusion Lumos
- Access type
- open
- Tissue preservation
- Not reported
- WHO edition
- Not reported
Cohort detail
- Grade breakdown
- Not reported
- Sex distribution
- Not reported
- Age distribution
- Not reported
- Anatomic location
- Not reported
- Brain invasion
- Not reported
- Normal/control tissue
- Not reported (n=2)
Priority attributes
Molecular subtype annotatedPeer-reviewed
Publications
- Shah M, et al. Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas. EBioMedicine, 2025. PMID 40562609 · DOI